Literature DB >> 2364167

A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients.

L Sainati1, E Matutes, S Mulligan, M P de Oliveira, S Rani, I A Lampert, D Catovsky.   

Abstract

We describe the clinical and laboratory features of 17 adult patients with a variant form of hairy cell leukemia (HCL-V) studied over the last 7 years. The main findings were: splenomegaly, moderate anemia, thrombocytopenia, and a raised white blood cell count (median 116 x 10(9)/L; range 15 to 482). The circulating lymphoid cells had abundant villous cytoplasm and a round, occasionally bilobed nucleus, with a prominent nucleolus. Monocytopenia, a feature of typical HCL, was not seen; neither was tartrate-resistant acid phosphatase demonstrated in eight cases tested. HCL-V cells had a mature B-cell phenotype: CD19+, CD20+, CD22+, FMC7+, CD11c+, CD10-, CD5-, with light chain isotope restriction in 15 cases. In contrast to typical hairy cells, HCL-V cells were negative with the monoclonal antibodies anti-HC2 and anti-TAC (CD25). Immunoglobulin (Ig) was not detected in two cases and IgG was expressed in the cell membrane of 73% of cases. Bone marrow histology was different from HCL, showing interstitial infiltration by cells clumped together and a moderate amount of reticulin, but the spleen showed the typical red pulp expansion of HCL. HCL-V patients did not respond to splenectomy (5 of 7) or alpha-interferon (7 of 7); 2 of 3 patients had a partial response to 2'deoxycoformycin. The clinical course was benign with 15 patients alive with a median survival greater than 4 years. We confirm that HCL-V is a distinct clinico-pathologic entity with intermediate features between HCL and B-prolymphocytic leukemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2364167

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  Hairy cell leukemia.

Authors:  Ronan Swords; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  Phase II clinical study of cladribine in the treatment of hairy cell leukemia.

Authors:  Takashi Machii; Takaaki Chou; Muneou Suzuki; Yokiko Ohe; Shuichi Katagiri; E Kiyoshi Kitano; Kiyoshi Kitano; Yoshihide Fujiyama; Tooru Izumi; Chihiro Shimazaki; Koji Nanba; Yasuo Ohashi; Teruo Kitani
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

3.  Hairy cell leukaemia variant with periarticular joint infiltration and excellent radiotherapy response.

Authors:  Michael J McKay; Kirsty L Rady; Thomas A McKay
Journal:  Ann Transl Med       Date:  2017-04

4.  Diagnostic relevance of peripheral blood immunocytochemistry in hairy cell leukaemia.

Authors:  I Cordone; L Annino; S Masi; E Pescarmona; S Rahimi; A Ferrari; E Giubilei; P Pignoloni; T Faraggiana; F Mandelli
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

Review 5.  Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders. General Haematology Task Force of BCSH.

Authors: 
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

6.  Hairy cell leukemia: clinicopathological and immunophenotypic study.

Authors:  Kaumudi Konkay; Megha S Uppin; Shantveer G Uppin; D Raghunadha Rao; Ch Geetha; T Roshni Paul
Journal:  Indian J Hematol Blood Transfus       Date:  2013-02-06       Impact factor: 0.900

7.  A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies--a tissue microarray study.

Authors:  Judit Tóth-Lipták; Klára Piukovics; Zita Borbényi; Judit Demeter; Enikő Bagdi; László Krenács
Journal:  Pathol Oncol Res       Date:  2014-06-06       Impact factor: 3.201

8.  Monoclonal antibody HBME-1 reacts with a minor subset of B cells with villous surface and can be useful in the diagnosis of hairy cell leukemia and other indolent lymphoproliferations of villous B lymphocytes.

Authors:  László Krenács; Judit Tóth-Lipták; Judit Demeter; Klára Piukovics; Zita Borbényi; Péter Gogolák; Eszter Sári; Enikő Bagdi
Journal:  Virchows Arch       Date:  2013-10-05       Impact factor: 4.064

9.  Hairy cell leukemia with unusual loss of CD103 in a subset of the neoplastic population: immunophenotypic and cell cycle analysis by flow cytometry.

Authors:  Constance M Yuan; Li-Jun Yang
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

10.  Hairy cell leukaemia: a heterogeneous disease?

Authors:  Graça M Dores; Rayna K Matsuno; Dennis D Weisenburger; Philip S Rosenberg; William F Anderson
Journal:  Br J Haematol       Date:  2008-05-08       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.